Top Global Biopharmas Standardize on Veeva China CRM Suite
Veeva Systems (NYSE: VEEV) has announced that 6 of the top 20 biopharmas have selected Veeva China CRM Suite for healthcare professional (HCP) engagement in China. The suite is specifically developed in China for China, while adhering to Veeva's global development standards for compliance and quality.
The China-specific solution includes local requirements and technologies, in-country hosting, and compliance with privacy and data export regulations. The suite comprises several applications including China CRM, China Events Management, Approved WeChat, China Engage, and China Campaign Manager.
As part of Veeva Commercial Cloud, the global technology foundation for commercial excellence, the suite integrates seamlessly with other Veeva products such as PromoMats, Network, and OpenData.
Veeva Systems (NYSE: VEEV) ha annunciato che 6 delle prime 20 biopharma hanno scelto Veeva China CRM Suite per l'engagement con i professionisti sanitari (HCP) in Cina. La suite è stata sviluppata specificamente in Cina per la Cina, mantenendo gli standard di sviluppo globale di Veeva per conformità e qualità.
La soluzione specifica per la Cina include requisiti e tecnologie locali, hosting nel paese e conformità alle normative sulla privacy e sull'esportazione dei dati. La suite comprende diverse applicazioni tra cui China CRM, China Events Management, Approved WeChat, China Engage e China Campaign Manager.
Come parte di Veeva Commercial Cloud, la fondazione tecnologica globale per l'eccellenza commerciale, la suite si integra perfettamente con altri prodotti Veeva come PromoMats, Network e OpenData.
Veeva Systems (NYSE: VEEV) ha anunciado que 6 de las 20 principales biopharmas han seleccionado Veeva China CRM Suite para la interacción con profesionales de la salud (HCP) en China. La suite ha sido desarrollada específicamente en China para China, cumpliendo con los estándares de desarrollo global de Veeva en cuanto a cumplimiento y calidad.
La solución específica para China incluye requisitos y tecnologías locales, alojamiento en el país y cumplimiento de las regulaciones de privacidad y exportación de datos. La suite comprende varias aplicaciones, incluyendo China CRM, China Events Management, Approved WeChat, China Engage y China Campaign Manager.
Como parte de Veeva Commercial Cloud, la base tecnológica global para la excelencia comercial, la suite se integra sin problemas con otros productos de Veeva como PromoMats, Network y OpenData.
Veeva Systems (NYSE: VEEV)는 20대 바이오제약 회사 중 6곳이 중국에서 의료 전문가(HCP)와의 소통을 위해 Veeva China CRM Suite를 선택했다고 발표했습니다. 이 제품군은 중국을 위해 특별히 개발되었으며, Veeva의 글로벌 개발 기준에 따라 준수 및 품질을 유지합니다.
중국 특화 솔루션은 현지 요구 사항 및 기술, 현지 호스팅, 개인정보 및 데이터 수출 규정 준수를 포함합니다. 이 제품군은 China CRM, China Events Management, Approved WeChat, China Engage 및 China Campaign Manager와 같은 여러 응용 프로그램으로 구성됩니다.
Veeva Commercial Cloud의 일환으로, 상업적 우수성을 위한 글로벌 기술 기반인 이 제품군은 PromoMats, Network 및 OpenData와 같은 다른 Veeva 제품과 원활하게 통합됩니다.
Veeva Systems (NYSE: VEEV) a annoncé que 6 des 20 principales biopharmas ont choisi Veeva China CRM Suite pour l'engagement des professionnels de santé (HCP) en Chine. La suite a été spécifiquement développée en Chine pour la Chine, tout en respectant les normes de développement mondiales de Veeva en matière de conformité et de qualité.
La solution spécifique à la Chine comprend des exigences et des technologies locales, un hébergement dans le pays et le respect des réglementations sur la vie privée et l'exportation des données. La suite comprend plusieurs applications, dont China CRM, China Events Management, Approved WeChat, China Engage et China Campaign Manager.
Dans le cadre de Veeva Commercial Cloud, la fondation technologique mondiale pour l'excellence commerciale, la suite s'intègre parfaitement avec d'autres produits Veeva tels que PromoMats, Network et OpenData.
Veeva Systems (NYSE: VEEV) hat bekannt gegeben, dass 6 der 20 größten Biopharma-Unternehmen Veeva China CRM Suite für die Interaktion mit Gesundheitsfachleuten (HCP) in China ausgewählt haben. Die Suite wurde speziell in China für China entwickelt und hält sich an die globalen Entwicklungsstandards von Veeva in Bezug auf Compliance und Qualität.
Die China-spezifische Lösung umfasst lokale Anforderungen und Technologien, Hosting im Land sowie die Einhaltung von Datenschutz- und Datenexportvorschriften. Die Suite besteht aus mehreren Anwendungen, darunter China CRM, China Events Management, Approved WeChat, China Engage und China Campaign Manager.
Als Teil der Veeva Commercial Cloud, der globalen technologischen Grundlage für kommerzielle Exzellenz, integriert sich die Suite nahtlos mit anderen Veeva-Produkten wie PromoMats, Network und OpenData.
- Market leadership: Dominant position as standard CRM for multinational corporations in China
- Strategic expansion: Secured 6 of top 20 global biopharma clients
- Localized compliance: Full alignment with China's privacy and data requirements
- None.
6 of the top 20 biopharmas have chosen Veeva for
"Veeva China CRM Suite is being used by more global biopharmas than any other CRM in
Veeva China CRM Suite is part of Veeva Commercial Cloud, the global technology foundation for commercial excellence. Veeva China CRM Suite includes
Additional Information
For more on Veeva China CRM Suite, visit: veeva.com/cn/veeva-china-crm-suite-en
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
Forward-looking Statements
This release contains forward-looking statements regarding Veeva's products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10- Q for the period ended October 31, 2024, which you can find here (a summary of risks which may impact our business can be found on pages 36 and 37), and in our subsequent SEC filings, which you can access at sec.gov.
Contact:
| |
Lotus Cai |
View original content to download multimedia:https://www.prnewswire.com/news-releases/top-global-biopharmas-standardize-on-veeva-china-crm-suite-302389248.html
SOURCE Veeva Systems
FAQ
How many top biopharma companies have adopted Veeva China CRM Suite?
What specific features does Veeva China CRM Suite (VEEV) include?
How does Veeva ensure compliance in its China CRM Suite (VEEV)?
Which Veeva products integrate with the China CRM Suite (VEEV)?
